Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Humanised anti-CD37 monoclonal antibody conjugated to maytansinoid DM1

EU orphan designation number: EU/3/15/1494   
Active ingredient: Humanised anti-CD37 monoclonal antibody conjugated to maytansinoid DM1
Indication: Treatment of diffuse large B-cell lymphoma
Sponsor: Voisin Consulting S.A.R.L.
64, Avenue Pierre Grenier, 92100 Boulogne Billancourt, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
26/05/2015 Orphan designation EMA/OD/005/15 (2015)3574 of 21/05/2015
10/07/2017 Transfer of orphan designation EMA/OD/005/15/T/01 (2017)4920 of 06/07/2017